Home › Neuroendocrine Tumors › Texas › Dallas
Neuroendocrine Tumors clinical trials in Dallas, TX
6 studies for Neuroendocrine Tumors are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- UT Southwestern Medical Center, Dallas
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
RecruitingObservational study
- Clinical Research Institute at Methodist Health System, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingPhase 4
- UT Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Dallas
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- Salt Lake City, UT8 studies
- St. Louis, MO8 studies
- Columbus, OH8 studies
- Detroit, MI7 studies
- Cedar Rapids, IA7 studies
- Cleveland, OH7 studies
- New York City, NY7 studies
- Miami, FL7 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure42 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.